"At Sansum Clinic in Solvang, CA, our mission is to provide an excellent healthcare experience, recognizing our first priority is the patients we serve."

During the past decade, Santa Barbara Hematology Oncology - Solvang conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Santa Barbara Hematology Oncology - Solvang" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 1 trials, followed by "GOG Foundation" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored, "SWOG Cancer Research Network" with 1 trials sponsored and "Translational Oncology Research International" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Santa Barbara Hematology Oncology - Solvang" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Santa Barbara Hematology Oncology - Solvang" are "Breast Cancer" (2 trials), "Breast Adenocarcinoma" (1 trials), "Hormone Receptor Positive" (1 trials), "Neurotoxicity" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Santa Barbara Hematology Oncology - Solvang" in a lesser frequency.

Most popular intervention types in "Santa Barbara Hematology Oncology - Solvang" are "Drug" (5 trials), "Other" (3 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Quality-of-Life Assessment" (2 trials), "Anastrozole" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Santa Barbara Hematology Oncology - Solvang" are 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Santa Barbara Hematology Oncology - Solvang". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Santa Barbara Hematology Oncology - Solvang, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Santa Barbara Hematology Oncology - Solvang, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".